ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,114.63
-0.01%
Dow Jones
44,546.08
-0.37%
US Dollar vs MXN
20.31065
0.02%
Brent Oil
74.665
0.58%
Bitcoin
96,280.10
0.13%
Pepperstone
Advertisement
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Metagenomi Inc (MGX) Cotización

Metagenomi Inc

Metagenomi Inc (MGX)

Mount Gibson Iron Limited
2.61
0.16
(6.53%)
Cerrado 17 Febrero 3:00PM
Delayed by 15 minutes
2.63
0.02
(0.77%)
Fuera de horario: 6:12PM
Delayed by 15 minutes

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Estadísticas y detalles clave

Último Precio
2.63
Postura de Compra
2.63
Postura de Venta
2.77
Volume Operado de la Acción
978,517
2.47 Rango del Día 2.8199
1.61 Rango de 52 semanas 12.74
Capitalización de Mercado [m]
98.425M
Precio Anterior
2.45
Precio de Apertura
2.47
Hora
9
@
2.63
Última hora de negociación
Volumen financiero
US$ 2,651,531
Precio Promedio Ponderado
2.7097
Volumen promedio (3 m)
2,527,077
Acciones en circulación
37,423,917
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-1.43
Beneficio por acción (BPA)
-1.82
turnover
44.76M
Beneficio neto
-68.26M

Acerca de Metagenomi Inc

At Metageno-mi, we are cre-at-ing poten-tial-ly cura-tive ther-a-peu-tics using our metage--nomics-pow-ered genome edit-ing toolbox.We believe tools with capa-bil-i-ties that go beyond the cur-rent tech-nol-o-gy land-scape will be required in order to reach the full ther-a-peu-tic poten-tial of geno... At Metageno-mi, we are cre-at-ing poten-tial-ly cura-tive ther-a-peu-tics using our metage--nomics-pow-ered genome edit-ing toolbox.We believe tools with capa-bil-i-ties that go beyond the cur-rent tech-nol-o-gy land-scape will be required in order to reach the full ther-a-peu-tic poten-tial of genome edit-ing. By har-ness-ing the pow-er of metage-nomics, the study of genomes recov-ered from uncul-ti-vat-ed organ-isms in the nat-ur-al envi-ron-ment, we are dis-cov-er-ing and devel-op-ing a suite of nov-el genome edit-ing tools with the poten-tial to make any desired ther-a-peu-tic gene edit, any-where in the human genome. Mostrar más

Sector
Biological Pds,ex Diagnstics
Industria
Biological Pds,ex Diagnstics
Sitio web
www.metagenomi.co
Sede
Wilmington, Delaware, USA
Fundado
-
Metagenomi Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker MGX. The last closing price for Metagenomi was US$2.45. Over the last year, Metagenomi shares have traded in a share price range of US$ 1.61 to US$ 12.74.

Metagenomi currently has 37,423,917 shares in issue. The market capitalisation of Metagenomi is US$91.69 million. Metagenomi has a price to earnings ratio (PE ratio) of -1.43.

MGX Últimas noticias

Más noticias

Form 8-K - Current report
Edgar (US Regulatory)
16 Enero 2025
MGX (6.53%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
06 Diciembre 2024
MGX (6.53%)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.020.7662835249042.612.7682.254790992.41198854CS
4-0.15-5.395683453242.7842.2517251792.84960406CS
120.7741.39784946241.864.921.7425270773.67997874CS
26-0.77-22.64705882353.44.921.6112724043.47517316CS
52-8.42-76.199095022611.0512.741.616947673.83539363CS
156-7.62-74.341463414610.2512.741.616990073.96148777CS
260-7.62-74.341463414610.2512.741.616990073.96148777CS

MGX - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Metagenomi?
El precio actual de las acciones de Metagenomi es US$ 2.63
¿Cuántas acciones de Metagenomi están en circulación?
Metagenomi tiene 37,423,917 acciones en circulación
¿Cuál es la capitalización de mercado de Metagenomi?
La capitalización de mercado de Metagenomi es USD 91.69M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Metagenomi?
Metagenomi ha negociado en un rango de US$ 1.61 a US$ 12.74 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Metagenomi?
El ratio precio/beneficio de Metagenomi es -1.43
¿Cuál es el ratio de efectivo a ventas de Metagenomi?
El ratio de efectivo a ventas de Metagenomi es 2.18
¿Cuál es la moneda de reporte de Metagenomi?
Metagenomi presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Metagenomi?
El último ingresos anual de Metagenomi es USD 44.76M
¿Cuál es el último beneficio anual de Metagenomi?
El último beneficio anual de Metagenomi es USD -68.26M
¿Cuál es la dirección registrada de Metagenomi?
La dirección registrada de Metagenomi es 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
¿Cuál es la dirección del sitio web de Metagenomi?
La dirección del sitio web de Metagenomi es www.metagenomi.co
¿En qué sector industrial opera Metagenomi?
Metagenomi opera en el sector BIOLOGICAL PDS,EX DIAGNSTICS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
JTAIJet AI Inc
US$ 6.02
(133.33%)
101.64M
SRMSRM Entertainment Inc
US$ 0.6999
(95.50%)
248.48M
WRDWeRide Inc
US$ 31.4877
(83.39%)
20.57M
INLFINLIF Limited
US$ 16.27
(80.58%)
7.67M
MBRXMoleculin Biotech Inc
US$ 2.1201
(66.94%)
134.88M
BLACBellevue Life Sciences Acquisition Corporation
US$ 3.08
(-56.31%)
430.77k
BLACUBellevue Life Sciences Acquisition Corporation
US$ 3.36
(-52.68%)
5.21k
CSAICloudastructure Inc
US$ 19.0001
(-49.58%)
1.03M
NEXNNexxen International Ltd
US$ 10.30
(-49.16%)
164.82k
BSLKBolt Projects Holdings Inc
US$ 0.6626
(-46.13%)
13.4M
CNSPCNS Pharmaceuticals Inc
US$ 0.1415
(31.26%)
489.28M
MGOLMGO Global Inc
US$ 0.7176
(-15.08%)
417.31M
SRMSRM Entertainment Inc
US$ 0.6999
(95.50%)
254.39M
INTCIntel Corporation
US$ 23.60
(-2.20%)
230.26M
NVDANVIDIA Corporation
US$ 138.85
(2.63%)
194.99M

MGX Discussion

Ver más
tw0122 tw0122 4 semanas hace
MGX $3.28 + 20% Gene editing AI play juice it $3.77-$4,03 in cards 
👍 1
theorysuit theorysuit 4 semanas hace
LFG, she got her 2nd Wind!
👍 1
theorysuit theorysuit 2 meses hace
1.81 to 4.92 with a normal retrace of 2.92. This stock still trades at under cash value. I have near to mid term fib targets of 6, 6.49, 6.87, 7.21, 7.58, 7.95, and 8.47 if you are looking for some exit points.
👍️0
Landwehr Landwehr 2 meses hace
I enjoy the violatility of this stock. However, a news release will get us past 5.00 and into 6s
👍️0
KIPK KIPK 2 meses hace
A true theorySLUT paid to post theorySHIT on multiple massage boards..

KARMA in not a theory, Its a selftrap for good...
👍️0
Landwehr Landwehr 2 meses hace
There hasn't been any news in a while. However, the chart is looking really good
👍️0
Monksdream Monksdream 2 meses hace
MGX under $5

[color=red][/color]
👍 1
Landwehr Landwehr 2 meses hace
MGX still looking good. A mild new release will send this to 4.5. 
👍️0
TrendTrade2016 TrendTrade2016 2 meses hace
GAVE IT A CHANCE...SOLD IT
👍️0
Landwehr Landwehr 2 meses hace
We need a news release for this to go back up. I'm long on this stock 
👍️0
TrendTrade2016 TrendTrade2016 2 meses hace
MGX GAPPING BACK UP...LAST ATTEMPT
👍️0
Landwehr Landwehr 2 meses hace
If we can continue to consolidate and churn in this range for a few days we will be in good shape for the next news cycle. 
👍️0
TrendTrade2016 TrendTrade2016 2 meses hace
5 DAY DOWN TREND SEEMS TO HAVE STOPPED
👍️0
Landwehr Landwehr 2 meses hace
Very good consolidation while no new news
👍️0
TrendTrade2016 TrendTrade2016 2 meses hace
MGX BUILDING A FOUNDATION
👍 1
Landwehr Landwehr 2 meses hace
The next news release will ignite this stock. 
👍️0
dinogreeves dinogreeves 2 meses hace
No, they are well funded well into 2025 and even beyond late 2025.
👍️0
Millenium323 Millenium323 2 meses hace
Bayer Healthcare bought a 10.8% stake in $MGX according to a Nov 6th filing. Bayer is a multibillion dollar company who is known for their Hemophilia Division. This happens to correspond to MGX's strength which is their Hemophilia pipeline

https://www.otcmarkets.com/filing/html?id=17946805&guid=3xY-kK_WErmSJth
👍 1
Landwehr Landwehr 2 meses hace
This is going to be a fun ride. Alot of volatility. It will get back close to 10 in the next couple months. Even if it's speculation 
👍️0
dinogreeves dinogreeves 2 meses hace
I sold at $4.50.
👍️0
frans frans 2 meses hace
MGX need money ???
👍️0
frans frans 2 meses hace
MGX company work for MM not for shaholders and selling shares into market
👍️0
frans frans 2 meses hace
all schort what I see on my L2 MM's 10 - 12 sametime
👍️0
theorysuit theorysuit 2 meses hace
This is how these bios move. You get the early stage upwave which we are in. They will bring it down closer to commercialization again. Ride this upwave and expect periods of pullbacks and consolidation.
👍️0
Landwehr Landwehr 2 meses hace
I wouldn't consider this stock a pump and dump. I do agree on the way to the 52 week low that shook alot of weak hands. Now with three sources of revenue and some of their products entering a new phase before production, this stock is getting noticed 
👍️0
frans frans 2 meses hace
I am not out I am long
👍️0
theorysuit theorysuit 2 meses hace
Stage 1 pump. They shook everyone out on the drive to 1.60. This is how stocks move.
👍️0
Landwehr Landwehr 2 meses hace
A ride to $10
👍️0
frans frans 2 meses hace
what is going on here ??
👍️0
TrendTrade2016 TrendTrade2016 2 meses hace
MGX MONSTER
👍️0
dinogreeves dinogreeves 2 meses hace
This is why it ran today with no news, someone knew it was coming

https://finance.yahoo.com/news/metagenomi-presents-updated-preclinical-data-021600360.html
👍️0
dinogreeves dinogreeves 2 meses hace
Corporate presentation just an hour ago.

https://dbzipdrh8te83.cloudfront.net/MGX-ASH-December-2024.pdf
👍️0
dinogreeves dinogreeves 2 meses hace
Great update! Hemophilia drug market was estimated to be 12.1 billion this year. 18.7 billion by 2034. I wonder how much they’ll charge for a cure….. or governments will pay for it. Amazing opportunity here. Stoked for the years ahead.
👍️0
dinogreeves dinogreeves 2 meses hace
https://metagenomi.co/discovery-platform
👍️0
dinogreeves dinogreeves 2 meses hace
This has 8-10 dollars written all over it in a week. Gene therapy is huge market, very huge.
👍️0
dinogreeves dinogreeves 2 meses hace
Yup, this is real good one, I am still holding. Bought, then went out of the house to run errands. Over 7 dollars book value and revenues.
👍 1
Monksdream Monksdream 2 meses hace
Metagenomi, Inc. is a precision genetic medicines company, which engages in the business of developing next generation gene-editing technologies and therapies. Its business activities include developing gene edit­ing toolbox, ther­a­peu­tic focus, and processing discovery platform. The company was founded by Brian C. Thomas on September 16, 2016 and is headquartered in Emeryville, CA. The listed name for MGX is Metagenomi, Inc. Common Stock
👍️0
Monksdream Monksdream 2 meses hace
UP OFF THE MAT, maybe it will grow legs
👍️0
Landwehr Landwehr 2 meses hace
This could get to $5 this week
👍️0
glenn1919 glenn1919 2 meses hace
MGX..................https://stockcharts.com/h-sc/ui?s=MGX&p=W&b=5&g=0&id=p86431144783
👍 1
eur06 eur06 2 meses hace
Just got on line….it looks pretty good!!
Trying to get some.
👍️0
theorysuit theorysuit 2 meses hace
LfG!
👍️0
dinogreeves dinogreeves 2 meses hace
Will run to 10 dollars within a week. Insiders and Tutes bought above 10 dollars.
👍 1
TrendTrade2016 TrendTrade2016 2 meses hace
mgx blowing up
👍️0
dinogreeves dinogreeves 2 meses hace
1000% gains coming here, jumped in at 2.28 this morning with 4000 shares.
👍 1
KIPK KIPK 5 meses hace
POS ....You are
👍️0
KIPK KIPK 5 meses hace
You are a POS dude....
👍️0
theorysuit theorysuit 5 meses hace
Added again here in full size. Data looks fantastic.
👍️0
theorysuit theorysuit 5 meses hace
https://finance.yahoo.com/news/metagenomi-announces-preclinical-data-lead-200500503.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr

Efficacy and Durability looks promising here. Lotto sized play here sub $3. I think Stage 1 Pump incoming. A deal to replace MRNA would be nice.
👍️0
theorysuit theorysuit 6 meses hace
buying in small chunks under $3.
👍️0

Su Consulta Reciente

NASDAQ
MGX
Metagenomi
NYSE
EMN
Eastman Chemical
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios